Member Info for dactions

Thank goodness you've turned up - this board 's been so quiet without the likes of your ramping.

@schalfplanet
What are you expecting to read in your RNS tomorrow?

@jamrock
Don't disagree with your comments - the outlook for us as shareholders is really positive. We can expect some positive lift this week ahead with the real growth coming once the full year's results are announced and analysed by the financial pundits.
I found what I was looking for on the website - I'd overlooked that it's under the DNA testing section:
https://myhealthchecked.com/at-home-dna-testing

Are these the products then now being shown on the MHC website yesterday - are they all coming soon ?
I'm unable to re-find the pages but they were listed in this order (no prices were shown):

- Vegan Suitability 'marked coming soon'
- Lactose Intolerance
- Coelic Test
- Caffeine Sensitivity
- Alcohol Sensitivity

I notice the closing mid price was later lowered from 3.05p down to 2.88p - I've never understood that aspect of the Market Makers. Also, today a late trade shown from Thursday of 1m shares @ 2.5625 which at that time would have been a Sell. In fact it's a few large Sells that are keeping the sp down.

Hopefully though, should still be a positive day Monday.

Good to see some recovery in price at the end of the day. At least for us MHC shareholders a good sign for Monday. GLA

There was a point this morning when I could have cleared the whole of my holding at 3.13p - I reckoned there was a good chance to trade but I've set my initial target to 3.5p and being a non-trader really, I'm content in the knowledge that the route is clear for an upward trend.

With the BoD adeptly taking on the LFT business, plus the liklihood of PCR tests, cash in the bank as well as new products . . . . . . well, it's all looking good for an MHC shareholder (even if the pandemic is a miserable thing).

There's a little more to today's news I think but I'm not entirely sure I understand though.

Today's RNS announces Miles Pelham's vehicle Rhino Ventures holds voting rights which equates to 22.32% 414,599,000 shares. Previously he held 398,200,000 - a difference of 16,300,000.

We've just seen reported trades from yesterday all occurring around 12.55 - 13.01pm 25th November.
12.55pm 12millions @ 4.45p
12.59pm 1.3million @ 4.45p
13.01pm 13.3millions @ 4.5p

You'd think it was a tax bed & breakfast deal of some kind to look at those figures a financial difference of just £6650.
But there's another 3 million shares obtained from somewhere though. Either way, the figures underlie Miles Pelham's conviction that Woodbois is a worthwhile commercial risk.

Even though my holding is modest in comparison, it is becoming my largest share holding, as barring some crisis in Gabon, the present BoD now running the show, are doing remarkably well and I'm very sure that the end year figures will be excellent.

A great share to hold in my opinion. GLA

@palmsairport

Just for the record it was @smtrading who told us about the lateral flow tests probability after he called the company and asked the question. But I don't take away anything from @jamrock who keeps us all positive with his insightful comments.

Good to see the negative thread from Wolf76 seems to have been removed ? I feel sure that today's announcement from MHC is further evidence of a management that is quick to act and takes advantage of market conditions. Augurs well for the new year's trading.

@Rob_
In my opinion the relative extremes of movement are simply down to market sentiment concerned that MHC wouldn't be able to sustain it's high level of trading should COVID-19 disappear as some were thinking/hoping for in the Summer. MHC has shown it is fleet of foot and for a young newcomer is showing very credible business strengths. GLA

I'm beginning to wonder if I'm the only sane one on this bulletin board ? What with talk of Basher, Mike the Bike on ADVFN, the Three Receommendations all littered between umpteen [Filtered] boxes.

However, although I have nothing other than an instinct that some decent commercial news is likely soon, I made a
small top-up of 6320 shares today to give me a nicer round figure to my long term holding. I'd like to think we'll soon be out of the 30s trading range.

Come on FUM, make my day and put a stop to all these [Filtered] boxes.

Excellent title to this thread @panicattack.

Today's news shows how adaptable this company has become - priced at £20 they are showing great skill in developing the business. I liked this bit in the announcement particularly:
"MyHealthChecked remains a high-quality laboratory provider but has adapted to evolving market requirements, allowing the Company's reputation for delivering a good customer experience and a reliable testing service across a wider variety of testing formats."

GLA

@LordPaul - as I said in my previous post I like to seek our shares that, whilst they may gyrate up and down, nevertheless are trending positive. In reality, there's nothing clever about that as what we're all seeking. I tend not to trade shares as I don't want to commit to the time needed - and I do firmly believe you'll never make a successful trader unless you are prepared to give over the working day to watching your shares.

That said I've been in Synairgen for years and could have made a bomb given the almost predictable swings it's had - as much as 50p plus but even though I've been an investor in shares for decades, I too have to learn the gyrations and each share seems to be unique in its performance patterns.

But with MHC, there's a good possibility it will follow a steady upward path. My immediate target is 3.5p and when it reaches that I will reassess what I will do. For example, could I take the funds out and reinvest them elsewhere ? One key advantage we have over the BoD and major Institutional Investors is that our holdings, being relatively smaller, can be quickly sold off if needed.

Dependent on the new products, my target Spring-time next year would be 5p but the target will change based on BoD announcements end year results etc and whether the new products have good commercial prospects. They were quick to spot the Covid-19 opportunity and I think it's fair to say they played a blinder. With that good business acumen, the company could score well again.

@palmsairport comments about top-slicing are well worth checking.

Hope that helps.

@sexykiwi59

Wow - the TrustPilot ratings for this firm Recova-19 at 1.3 couldn't get much worse - they are dreadful and I'm really surprised Boots are tied up with them. Thank goodness we're with MHC which has a splendid satisfaction rating of 4.3.

You'll be doing us all a favour if you let MHC know of your personal experience mentioning Boots and which led to a bad experience with Recova-19 rather than an expected good experience with MHC.

"I just love this company but I will sell out when I hit my target as I have been stung a few times on the AIM market."

LordPaul - the stockmarket expression is 'cut your losses' but 'let your winners run'. You'll not do well on the stockmarket if you do the opposite. I don't mean to be trite but 'jamrock' has a point that if you liked the share at 5p - what's not to like at 2p. If you're newish to the market, it's worth taking it slower, not be in a hurry to top-up just because your share falls. There's no point averaging down if it is likely to keep going down - you need to stand back a little.

I think you've been in GDR and Hemo both of which have fallen badly - and of course we've seen MHC also fall badly. I know hindsight is a wonderful thing but whilst I don't go in for trading shares, I am seeking out small companies that I can hold on to and ride along with like Synairgen or Woodbois but if it is starting to look bad, I cut my losses like TP Group. Sometimes I find it easier to cut a loss if I think I can find a share that will progress.

Others might rubbish my comments, but if you'll forgive me, I think you're investing in the hope of landing it right on one share straight off and that takes a lot of luck just as much as research. The truth is that it rarely happens and you need to spread your investments.

You've taken a nasty hit even on MHC but there were others who were saying don't chase it up - I sold out middway and of course lost potential profit but was able to buy back in around the 2.6p mark and bought more when it fell below the 1.75p Directors own placing price. If MHC shareprice processes steadily, and if they come out with some meaningful new products, this could well be the share that will grow and grow and one to tuck away.

One other point I would make - if you have spare cash to invest - don't rush into an investment, hold back and keep eyes open for a worthwhile opportunity. You might say, cash isn't going to grow if it's not invested, but I've found that holding it in reserve, disciplines you for looking for even better investment opportunities and in time your investment expertise develops a little bit better.

All the best.

WIth polygon increasing its holding, it’s crazy the sp is only in the 170’s

The 'best companies' never chase their prices to the bottom - and MHC certainly doesn't need to do that, even more so, serving such substantial pedigree companie like Boots and Lloyds Pharmacy.

I've looked intensely at TrustPilot returns and it is quite clear, where problems have occurred the transaction has invariably been over a weekend and largely the fault of Royal Mail. How you fix that, I don't know but with a TrustPilot satisfaction rate of 4.3, clearly MHC are one of the 'best companies'.

I'm feeling like LordPaul - keep on adding - so I also decided to add again this morning at 1.87. It seems to me the shares at this level must have a chance of breaking out upwards given the wave of infections spreading through Europe.

GLA

These past years, it's been a remorseless drive to the bottom with Coro - so why today does it seem everybody, except me a LTH, knows something to lift the sp so positively ?

martinelwick - very interesting research you did there - and your observation about the phase III trial is which separates FUM from all the others is pot on.